These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer. Park MS; Lee SM Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer. Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372 [TBL] [Abstract][Full Text] [Related]
5. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454 [TBL] [Abstract][Full Text] [Related]
6. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. Petrowsky H; Wildbrett P; Husarik DB; Hany TF; Tam S; Jochum W; Clavien PA J Hepatol; 2006 Jul; 45(1):43-50. PubMed ID: 16690156 [TBL] [Abstract][Full Text] [Related]
7. The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma. Moon CM; Bang S; Chung JB Surg Oncol; 2011 Mar; 20(1):e10-7. PubMed ID: 19804967 [TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. Anderson CD; Rice MH; Pinson CW; Chapman WC; Chari RS; Delbeke D J Gastrointest Surg; 2004 Jan; 8(1):90-7. PubMed ID: 14746840 [TBL] [Abstract][Full Text] [Related]
10. Value of PET/CT in the management of primary hepatobiliary tumors, part 2. Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051 [TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes. Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM PET Clin; 2015 Jul; 10(3):327-43. PubMed ID: 26099670 [TBL] [Abstract][Full Text] [Related]
12. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis. Hu JH; Tang JH; Lin CH; Chu YY; Liu NJ J Investig Med; 2018 Jan; 66(1):52-61. PubMed ID: 28912249 [TBL] [Abstract][Full Text] [Related]
13. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer. Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710 [TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Kluge R; Schmidt F; Caca K; Barthel H; Hesse S; Georgi P; Seese A; Huster D; Berr F Hepatology; 2001 May; 33(5):1029-35. PubMed ID: 11343227 [TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Mori A; Doi R; Ikai I; Uemoto S Surgery; 2008 Jun; 143(6):769-77. PubMed ID: 18549893 [TBL] [Abstract][Full Text] [Related]
16. [18F-FDG PET/CT in staging and restaging cholangiocarcinoma]. Notaristefano A; Niccoli Asabella A; Stabile Ianora AA; Merenda N; Moschetta M; Antonica F; Altini C; Ferrari C; Cesarano E; Rubini G Recenti Prog Med; 2013; 104(7-8):328-35. PubMed ID: 24042402 [TBL] [Abstract][Full Text] [Related]
17. Staging and follow-up of gastrointestinal tumors with PET/CT. Rosenbaum SJ; Stergar H; Antoch G; Veit P; Bockisch A; Kühl H Abdom Imaging; 2006; 31(1):25-35. PubMed ID: 16333707 [TBL] [Abstract][Full Text] [Related]
18. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors. Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069 [TBL] [Abstract][Full Text] [Related]
19. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. Ruys AT; Bennink RJ; van Westreenen HL; Engelbrecht MR; Busch OR; Gouma DJ; van Gulik TM HPB (Oxford); 2011 Apr; 13(4):256-62. PubMed ID: 21418131 [TBL] [Abstract][Full Text] [Related]
20. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Weber SM; DeMatteo RP; Fong Y; Blumgart LH; Jarnagin WR Ann Surg; 2002 Mar; 235(3):392-9. PubMed ID: 11882761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]